[CLINICAL EVALUATION OF THE USE OF A DRUG WITH FIBRINOLYTIC ACTION IN THE THERAPY OF GESTOSIS IN THE THIRD TRIMESTER].
D000959:Antihypertensive Agents; D004232:Diuretics; D004358:Drug Therapy; D005260:Female; D006801:Humans; D009525:Niacin; D009539:Nicotinic Acids; D010208:Papaverine; D011225:Pre-Eclampsia; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D013806:Theophylline; D015912:Thrombolytic Therapy
D000959:Antihypertensive Agents; D004232:Diuretics; D009539:Nicotinic Acids; D009525:Niacin; D013806:Theophylline; D010208:Papaverine
ANTIHYPERTENSIVE AGENTS; DIURETICS; DRUG THERAPY; NICOTINIC ACID; PAPAVERINE; PREGNANCY; PREGNANCY TOXEMIAS; THEOPHYLLINE
VALUTAZIONE CLINICA DELL'IMPIEGO DI UN FARMACO AD AZIONE FIBRINOLITICA NELLA TERAPIA DELLE GESTOSI DEL TERZO TRIMESTRE.